Clinical Affairs: Initiatives

Ongoing Initiatives

  • EULAR points to consider for remote care in rheumatic and musculoskeletal diseases (RMDs) 
    Convenors: Christian Dejaco and Annette de Thurah

  • Update of the EULAR 2020 provisional recommendations for the management of RMDs in the context of SARS-CoV-2
    Convenor: R.Landewé
     

Published Initiatives

  • EULAR points to consider on COVID-19 pathophysiology and immunomodulatory therapies from the Rheumatology Perspective
    Convenor: Xavier Mariette

  • EULAR recommendations for screening and prophylaxis for opportunistic and chronic infectious diseases
    Convenor: Kimme Hyrich

  • EULAR Classification criteria for haemochromatosis arthropathy
    Convenor: Patrick Kiely

  • Points to Consider for Conducting Clinical Trials in Individuals at risk of Rheumatoid Arthritis
    Convenor: Paul Emery

  • Development And Validation of a EULAR disease activity score in adult onset Still’s Disease:  the “DAVID” project
    Convenor: Roberto Giacomelli

  • Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatology
    Convenor: John Isaacs

  • EULAR Recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases (including SLE and the antiphospholipid syndrome)
    Convenor: Michael Nurmohamed/Maria Tektonidou

  • EULAR Recommendations /Points to Consider for the intra-articular treatment of arthropathies (including synoviorthesis)
    Convenor: Jaqueline Uson

  • Update of the EULAR recommendations for the diagnosis and the management of rheumatic immune-related adverse events due to cancer immunotherapy
    Convenor: Thierry Schaeverbeke

  • EULAR recommendations for the management of difficult to treat rheumatoid arthritis 
    Convenor: György Nagy

  • Development of EULAR points to consider/recommendations for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
    Convenor: Paul Studenic

  • EULAR New Classification Criteria for Hand Osteoarthritis
    Convenor: Margreet Kloppenburg

  • EULAR Systemic Sclerosis Impact of Disease (EULAR ScleroID) score
    Convenor: Oiver Distler/Turid Heiberg

 

Related information

EULAR/ACR collaborative projects

For initiatives with international relevance, the relevant standing committee from EULAR seeks collaboration with the quality-of-care committee of the American College of Rheumatology (ACR). This cooperation includes the development and validation of criteria sets for the development of recommendations regarding conducting clinical trials.

EULAR and ACR strive for a transparent and collaborative relationship in order to avoid overlaps and to identify and promote synergies.

Read more


Call for Task Force members

We look for experienced investigators in the mentioned fields of rheumatology. To apply as task force member, please send your one-page letter of interest to participate and a short CV to Simona Lupatin (simona.lupatin@eular.org).

Download SOPs selection of task force members